Hjem › Adenokarcinom i spiserøret › Pennsylvania › Philadelphia
Kliniske studier for Adenokarcinom i spiserøret i Philadelphia, PA
8 studier for Adenokarcinom i spiserøret søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RekruttererFase 2/3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi unna
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RekruttererFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Einstein Medical Center Philadelphia, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi unna
- og 2 flere
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RekruttererFase 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi unna
- Alliance Cancer Specialists, PC, Media · 12 mi unna
- Alliance Cancer Specialists, PC, Horsham · 16 mi unna
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Rekrutterer
- University of Pennsylania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
RekruttererFase 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Adenokarcinom i spiserøret-studier i andre byer
- New York City, NY18 studier
- Boston, MA13 studier
- Houston, TX12 studier
- Nashville, TN11 studier
- Arlington, VA11 studier
- Durham, NC10 studier
- Rochester, MN9 studier
- Baldwin Park, CA9 studier
- St. Louis, MO9 studier
- Jacksonville, FL9 studier
- Queens, NY9 studier
- Los Angeles, CA9 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.